Literature DB >> 24818112

Myeloma and diabetes mellitus.

Sora Yasri1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2014        PMID: 24818112      PMCID: PMC4014647          DOI: 10.4103/2278-330X.130469

Source DB:  PubMed          Journal:  South Asian J Cancer        ISSN: 2278-330X


× No keyword cloud information.
Dear Editor, The recent article on “myeloma and diabetes mellitus” is interesting.[1] Ali et al., noted that “the treatment of multiple myeloma and diabetes mellitus is multifaceted.”[1] In fact, diabetes mellitus is a common disorder in the present day. It is no doubt that diabetes mellitus can be seen in cancerous patients. For the concomitant diabetes mellitus and myeloma, a recent report by Ahmed et al., also proposed for the importance of this problem.[2] The concern is on the interrelationship between cancer and myeloma. It is proposed that the use of high doses of glucocorticoids in management of myeloma can result in diabetes mellitus. The follow up of blood glucose for the early detection of diabetes mellitus in the patients with myeloma is suggested.[3] On the other hand, Snowden et al., reported that “the plasma cell tumor was associated with excessive production of insulin-like peptides with consequent reduction in the blood glucose level.”[4] Hence, the observation of significant unexplained reduction of blood glucose in diabetic patient with myeloma might require intensive investigation on progress of malignancy.
  4 in total

1.  Reversal of diabetes associated with escape of myeloma: evidence for inappropriate IGF-II secretion.

Authors:  J A Snowden; M Greaves; K Page
Journal:  Br J Haematol       Date:  1994-05       Impact factor: 6.998

2.  [Disorder of glucose metabolism regulation in patients with multiple myeloma treated with high doses of corticosteroids at our clinic in 2004].

Authors:  Y Pospísilová; Z Adam
Journal:  Vnitr Lek       Date:  2007-01

Review 3.  Clinical challenges: myeloma and concomitant type 2 diabetes.

Authors:  Yasar Albushra Abdul Rahiem Ahmed; Awad Eltayeb
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

4.  Clinical challenges: Myeloma and concomitant type 2 diabetes.

Authors:  Mohamed Ahmed Ali; Yasar A Ahmed; Abubaker Ibrahim
Journal:  South Asian J Cancer       Date:  2013-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.